Iron Chloride
Iron chloride (FeCl₃, ferric chloride) is an inorganic iron salt used industrially as a coagulant and etching agent, not as a dietary supplement or therapeutic agent. Its strong Lewis acid properties and tissue corrosivity make it unsuitable and unsafe for internal administration in humans.

Origin & History
Iron chloride (FeCl₃), also known as ferric chloride, is an inorganic chemical compound produced industrially by reacting iron or iron ore with chlorine gas at 500–700°C or by oxidizing ferrous chloride. It appears as a dark green to black crystalline solid that is highly soluble in water (480 g/L at 20°C) and produces an acidic solution.
Historical & Cultural Context
No historical traditional medicine uses are documented in the research. FeCl₃ (flores martis) is identified as a modern industrial chemical without documented roles in traditional systems like Ayurveda, TCM, or herbalism.
Health Benefits
• No documented health benefits - research indicates FeCl₃ is corrosive to tissues and not studied for therapeutic use • No clinical trials or RCTs identified in the research for biomedical applications • Industrial chemical only - not evaluated for internal administration • Tissue corrosivity precludes any potential health benefits • No evidence quality available as no clinical studies exist
How It Works
Iron chloride dissociates in aqueous solution to release Fe³⁺ ions and chloride, generating a strongly acidic local environment that denatures proteins and oxidizes biological membranes via Fenton-like chemistry. At a physiological level, unbound Fe³⁺ catalyzes the conversion of hydrogen peroxide to hydroxyl radicals (OH•), causing oxidative damage to lipids, DNA, and cellular proteins. Unlike therapeutic iron salts such as ferrous sulfate or ferric maltol, FeCl₃ lacks stabilizing ligands that would allow safe mucosal absorption via duodenal DMT-1 transporters.
Scientific Research
No human clinical trials, RCTs, or meta-analyses were identified for ferric chloride as a biomedical ingredient. PubMed PMIDs are unavailable, as FeCl₃ is not studied clinically for therapeutic use but is noted for its corrosivity to tissues.
Clinical Summary
No clinical trials, randomized controlled studies, or peer-reviewed human intervention studies have evaluated iron chloride (FeCl₃) for any therapeutic or nutritional purpose. Animal toxicology studies document severe gastrointestinal mucosal corrosion and systemic iron overload toxicity upon oral exposure. Poison control and occupational health literature consistently classify FeCl₃ as a corrosive hazard rather than a biomedical agent. The complete absence of clinical evidence reflects the compound's industrial classification, not a gap in research funding.
Nutritional Profile
Iron(III) chloride (FeCl₃) is an inorganic salt composed of iron in the +3 oxidation state and chloride ions, with a molecular weight of 162.2 g/mol (anhydrous) or 270.3 g/mol (hexahydrate FeCl₃·6H₂O). It contains approximately 34.4% iron by weight (anhydrous form). However, this is an industrial/laboratory chemical — not a nutritional mineral supplement. It is highly hygroscopic, strongly acidic in solution (pH < 2 at moderate concentrations), and corrosive to biological tissues. It provides no vitamins, fiber, protein, or beneficial bioactive compounds. Bioavailability as an iron source is irrelevant because oral or internal administration causes chemical burns to mucous membranes, esophageal and gastric tissue damage, and potential systemic iron toxicity. It should not be confused with bioavailable supplemental iron forms such as ferrous sulfate, ferrous bisglycinate, or iron pyrophosphate. Its only recognized medical use is as a topical hemostatic agent (Monsel's solution, a ferric subsulfate derivative) applied externally to stop minor bleeding, not for nutritional purposes.
Preparation & Dosage
No clinically studied dosage ranges exist for ferric chloride, as it lacks biomedical applications and is not used therapeutically. The compound's tissue corrosivity precludes internal administration. Consult a healthcare provider before starting any new supplement.
Synergy & Pairings
Iron chloride has no nutritional or therapeutic synergy stack because it is not a supplement or food-grade ingredient. For individuals seeking actual iron supplementation, bioavailable forms such as ferrous bisglycinate pair synergistically with Vitamin C (ascorbic acid, 200–500 mg) which enhances non-heme iron absorption by reducing Fe³⁺ to the more absorbable Fe²⁺ form, Lactoferrin (100–200 mg) which facilitates intestinal iron uptake and reduces GI side effects, and Vitamin A/Beta-carotene (5,000–10,000 IU) which helps mobilize stored iron and counteracts the inhibitory effects of phytates and polyphenols on iron absorption. These synergies apply only to food-grade iron compounds and should never be extrapolated to industrial FeCl₃.
Safety & Interactions
Iron chloride is corrosive to skin, eyes, and mucous membranes and is classified as a hazardous substance by OSHA and the EU GHS system; oral ingestion can cause severe burns to the esophagus and gastrointestinal tract. Systemic absorption of excess Fe³⁺ may cause acute iron toxicity, manifesting as vomiting, metabolic acidosis, hepatotoxicity, and cardiovascular collapse at high doses. It should never be combined with antacids, proton pump inhibitors, or chelating agents in any supplementation context, as these interactions are entirely moot given that FeCl₃ is contraindicated for human consumption. It is absolutely contraindicated in pregnancy, pediatric populations, and all other demographics as an ingestible substance.